PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah Walsh MANAGING EDITOR Denise Myshko DIRECTOR OF SALES Darlene Kwiatkowski Copyright 2003 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A. Volume One, Number One VIEW is published as a supporting publication to PharmaVOICE which is published 12 times per year by PharmaLinx LLC, P.O. Box 327, Titusville, NJ 08560. Postmaster: Send address changes to PharmaVOICE, P.O. Box 327, Titusville, NJ 08560. VIEW and PharmaVOICE Coverage and Distribution: Domestic subscriptions are available at $160 for one year (12 issues plus VIEWs). Foreign subscriptions: 12 issues plus VIEWs US$330. Contact PharmaLinx at P.O. Box 327, Titusville, NJ 08560. Call us at 609.730.0196 or FAX your order to 609.730.0197. Contributions: The VIEW and PharmaVOICE is not responsible for unsolicited contributions of any type. Unless otherwise agreed in writing, The VIEW and PharmaVOICE retains all rights on material published in The VIEW and PharmaVOICE for a period of six months after publication and reprint rights after that period expires. Email: [email protected]. Change of address: Please allow six weeks for a change of address. Send your new address along with your subscription label to PharmaLinx LLC, P.O. Box 327, Titusville, NJ 08560. Call us at 609.730.0196 or FAX your change to 609.730.0197. Email: [email protected]. IMPORTANT NOTICE: The post office will not forward copies of this magazine. The VIEW and PharmaVOICE and not responsible for replacing undelivered copies due to lack of or late notification of address change. Advertising in VIEW or PharmaVOICE: To advertise in VIEW or PharmaVOICE please contact our Advertising Department at P.O. Box 327, Titusville, NJ 08560, or telephone us at 609.730.0196. Email: lban [email protected]. www.pharmavoice.com Volume 1 . Number 1 Send your letters to feedback@pharma linx.com. Please include your name, title, company, and business phone number. Let ters chosen for publication may be edited for length and clarity. All submissions become the property of PharmaLinx LLC. Welcome to the premiere issue of the VIEW — the first in a series of supporting publications to PharmaVOICE, PharmaLinx LLC’s flagship product. The impetus to develop and publish a series of VIEWs was in direct response to reader demand. As all publications ultimately are defined by their audiences, PharmaLinx endeavors to develop products and services that reflect the qualities of its readers who must be adaptive to change, who are open to new ideas and cutting edge business concepts, and who demand and expect quality. PharmaLinx’s goal is to continue to develop editorial products that address readers’ needs in a distinctly unique for mat. Multiple perspective editorial coverage has been and will continue to be tightly focused on how industry leaders are managing and operating in the dynamic and multifaceted life sciences sectors. Each VIEW includes a thought provoking Forum based on interviews with industry executives with a knowledge base in a particular sector. Each VIEW also includes one of a kind content contributed by industry leaders who provide solutions, products, and services to life science companies. Recently, issues affecting CME have become a more prominent feature of debate in the industry. Recognizing that the enterprise of continuing medical education touches myriad stakeholders who are grappling with new and emerging regulations and industry forces, PharmaLinx has responded with the VIEW on Medical Education. As new regulations begin to have a stabilizing, or destabilizing, effect on CME in the coming year the test for business leaders isn’t in forecasting the day of perfect alignment among all factions; the true test is whether they are laying the groundwork for future suc cess. As such, the industry needs to for tify its business enterprises with the necessary tools and information to gen erate optimum results. In the following pages, you will find articles by leading providers of services that address CME topics related to facil itating physician learning, the industry, medicaleducation and communication companies, regulators and regulations, and technology and program design. In addition, the Forum on CME pro vides original commentary from execu tives who are charged with adapting their organizations’ programs to be in regulatory compliance while developing relevant and meaningful content for physicians and other healthcare providers. We know you are busy and need genuine knowledge. After reading the VIEW on Medical Education, please take a moment to provide us with your feed bac, because for us, content is at the core of everything we do. A question naire has been provided and should only take a minute to fill out. If you prefer, you can answer the questions online at www.pharmalinx/view.com. All submis sions will remain confidential and are for the sole purpose of refining our editorial coverage for future endeavors. We at PharmaLinx look forward to bringing our readers new and exciting products that offer insight and value. Subsequent VIEWs will be published throughout 2004 covering the different areas of business that have Lisa Banket Publisher LETTER FROM THE PUBLISHER ON MEDICAL EDUCATION A SUPPORTING PUBLICATIONTO PHARMAVOICE

Download PDF